Evidence map›Paper›PMID 40437071›Full record

ArticleScientific reports2025

Development and characterization of hydroxyapatite and multiwall carbon nanotubes reinforced polypropylene biocomposites.

Abdel Rahman Elmofty, Marwa E Abdel Aziz, Mahmoud Tash, Shimaa El-Hadad

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Advancing Nanomedicine: For Bone Defect Repair and Regeneration.International journal of nanomedicine · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdel Rahman ElmoftyMining, Petroleum and Metallurgical Engineering Department, Faculty of Engineering, Cairo University, Giza, Egypt.
Marwa E Abdel AzizCentral Metallurgical Research and Development Institute, Helwan, Cairo, 11722, Egypt.
Mahmoud TashMining, Petroleum and Metallurgical Engineering Department, Faculty of Engineering, Cairo University, Giza, Egypt.
Shimaa El-HadadCentral Metallurgical Research and Development Institute, Helwan, Cairo, 11722, Egypt. shimahassan@cmrdi.sci.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two groups of Polypropylene/hydroxyapatite nanocomposites (PP/nHA) were fabricated by melt blending of PP with (5, 10, and 20 wt%) of hydroxyapatite nanoparticles nHA with two different sizes (~ 40 and 90 nm). The nanocomposites were prepared without and with the addition of 0.3 wt% of multiwall carbon nanotubes (MWCNTs). The effect of HA size and content as well as the addition of MWCNTs on the structure, thermal and mechanical properties of the prepared composites was investigated. All the samples were immersed in simulated body fluid (SBF) to compare their ability to precipitate HA from SBF. Scanning electron microscope (SEM), X-ray diffraction analysis (XRD), thermogravimetric analysis (TGA), and tensile strength tests were used for the investigation. XRD patterns reveal that incorporating nHA particles and/or MWCNT into the polymer matrix does not cause any structural change to the PP crystalline lattice. SEM shows a significant improvement in the dispersion of nHA particles along PP matrix with a smoother surface morphology by the addition of MWCNTs. Based on the thermal studies, both nHA particles and MWCNTS were known to enhance the thermal stability of the prepared composites. The tensile strength of PP increased by 20% for PP-5% (90 nm) HA-MWCNTs composites and 44% for PP-5% (40 nm) HA-MWCNTs composites. Furthermore, in vitro studies reveal the apatite-forming ability on the surface of the prepared composites especially those prepared using MWCNTs.

Indexed as

BiocompatibilityMultiwall carbon nanotubesNano-hydroxyapatitePolypropylene nanocomposites

Identifiers

PMID40437071
PMCPMC12119858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.